Bullish option flow detected in Corcept Therapeutics (CORT) with 1,069 calls trading, 1.2x expected, and implied vol increasing over 4 points to 74.07%. Feb-26 45 calls and Feb-26 30 puts are the most active options, with total volume in those strikes near 680 contracts. The Put/Call Ratio is 0.29. Earnings are expected on February 25th.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CORT:
- Corcept’s TRIDENT Trial: Early Oncology Bet in Metastatic Pancreatic Cancer
- Corcept’s Nenocorilant Combo Study Moves Forward, Expanding Its Oncology Ambitions
- Corcept Therapeutics put volume heavy and directionally bearish
- Corcept Therapeutics price target raised to $100 from $99 at Canaccord
- Corcept Therapeutics price target raised to $105 from $90 at H.C. Wainwright